TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched Metoprolol Tartrate 37.5 mg and 75 mg Tablets on the TruPharma label. The FDA-approved products are being supplied to TruPharma pursuant to a master agreement with Rubicon Research Private Limited. Significantly, Rubicon is one of only two companies to hold an FDA approval for these two strengths of Metoprolol Tartrate Tablets.